|
|
Line 17: |
Line 17: |
| <h3>Short Summary</h3> | | <h3>Short Summary</h3> |
| <div class="article"> | | <div class="article"> |
− | We started by validating the basic experiments required for the <i>in vivo</i> experiments with unnatural base pairs. A two-plasmid system for retention of unnatural base pairs was developed and characterized. In our <i>in vivo</i> experiment, we were able to detect unnatural base pairs in the specified target sequence using our adapted <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/development_of_new_methods#ONSseq">Oxford Nanopore Sequencing</a> after 24 hours. | + | We started by validating the basic requirements for the <i>in vivo</i> experiments with unnatural base pairs. A two-plasmid system for retention of unnatural base pairs was developed and characterized. In our <i>in vivo</i> experiment, we were able to detect unnatural base pairs in the specified target sequence using our adapted <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Results/unnatural_base_pair/development_of_new_methods#ONSseq">Oxford Nanopore Sequencing</a> after 48 hours. Furhter experiments need to be conducted for quantification of unnatural base retention efficiency. |
| | | |
| </div> | | </div> |
Line 298: |
Line 298: |
| | | |
| <article> | | <article> |
− | The Romesberg lab (Zhang <i>et al.</i>, 2017) was able to proof retention of their hydrophobic UBP in <i>E. coli</i> BL21(DE3) using the nucleotide transporter PtNTT2 and Cas9. Therefore we transformed <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> into <i>E. coli</i> BL21(DE3) via heat shock with the goal to produce chemically competent cells containing the retention plasmid afterwards. Those chemically competent cells were used for a second heat shock transformation of the second plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201032">BBa_K2201032</a> containing our UBP isoG-isoC<sup>m</sup>. 10 μL of the above described Gibson Assembly was transformed into chemically competent cells. After the heat shock, the cells were recovered in liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C for 1 h. Growth was performed in liquid growth media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin) while shaking at 600 rpm and 37 °C for 24 h. The described experimental set-up is shown in Figure 10. | + | The Romesberg lab (Zhang <i>et al.</i>, 2017) was able to proof retention of their hydrophobic UBP in <i>E. coli</i> BL21(DE3) using the nucleotide transporter PtNTT2 and Cas9. Therefore we transformed <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> into <i>E. coli</i> BL21(DE3) via heat shock with the goal to produce chemically competent cells containing the retention plasmid afterwards. Those chemically competent cells were used for a second heat shock transformation of the second plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201032">BBa_K2201032</a> containing our UBP isoG-isoC<sup>m</sup>. 10 μL of the above described Gibson Assembly was transformed into chemically competent cells. After the heat shock, the cells were recovered in liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C for 1 h. Growth was performed in liquid growth media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin) while shaking at 600 rpm and 37 °C for 48 h. The described experimental set-up is shown in Figure 10. |
| <br><br>K<sub>2</sub>HPO<sub>4</sub> is needed in the recovery and growth media as a competitive inhibitor for phosphatases. This prevents the dephosphorylation of unnatural nucleotide triphosphates. The IPTG in the media induces the expression of <i>cas9</i> that is negatively regulated by our designed <i>lac</i> operon (<a href=" http://parts.igem.org/Part:BBa_K2201020">lacO_tight1</a>) optimized for tight repression. This needs to be added right from the beginning after the transformation to start the retention system during recovery. For the same reason the isoGTP and isoC<sup>m</sup>TP were added to the recovery and growth media. | | <br><br>K<sub>2</sub>HPO<sub>4</sub> is needed in the recovery and growth media as a competitive inhibitor for phosphatases. This prevents the dephosphorylation of unnatural nucleotide triphosphates. The IPTG in the media induces the expression of <i>cas9</i> that is negatively regulated by our designed <i>lac</i> operon (<a href=" http://parts.igem.org/Part:BBa_K2201020">lacO_tight1</a>) optimized for tight repression. This needs to be added right from the beginning after the transformation to start the retention system during recovery. For the same reason the isoGTP and isoC<sup>m</sup>TP were added to the recovery and growth media. |
| | | |
Line 306: |
Line 306: |
| <img class="figure image" src="https://static.igem.org/mediawiki/2017/6/60/In_vivo_UBP_experimente_%C3%BCbersicht.png"> | | <img class="figure image" src="https://static.igem.org/mediawiki/2017/6/60/In_vivo_UBP_experimente_%C3%BCbersicht.png"> |
| <p class="figure subtitle"><b>Figure (10): Experimental flowchart for UBP retention <i>in vivo</i>.</b> | | <p class="figure subtitle"><b>Figure (10): Experimental flowchart for UBP retention <i>in vivo</i>.</b> |
− | <br>The pSB3C5 plasmid <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a> containing five sgRNAs and <i>mRFP-sacB</i> was linearized with the primers <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides">17tx and 17we</a> and assembled with <a href="">UBP_target</a> via Gibson Assembly. 10 μL of the Gibson Assembly was transformed into chemically competent <i>E. coli</i> BL21(DE3) cells containing the pSB1K3-plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a>. After the heat shock, the cells were recovered in 850 μL liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 1 h. Then, the recovery media was filled up with liquid growth media (2xYT media added with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin for final concentrations) up to 1 mL and shaked at 600 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 24 h. Plasmid isolations were performed for single 1 mL cultures. The high-copy plasmid pSB1K3 <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> was digested by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI. The remaining low-copy plasmid pSB3C5 containing the UBP was then prepared for the Oxford Nanopore Sequencing.</p> | + | <br>The pSB3C5 plasmid <a href=" http://parts.igem.org/Part:BBa_K2201032">BBa_K2201032</a> containing five sgRNAs and <i>mRFP-sacB</i> was linearized with the primers <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Oligonucleotides">17tx and 17we</a> and assembled with <a href="">UBP_target</a> via Gibson Assembly. 10 μL of the Gibson Assembly was transformed into chemically competent <i>E. coli</i> BL21(DE3) cells containing the pSB1K3-plasmid <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a>. After the heat shock, the cells were recovered in 850 μL liquid recovery media (2xYT media supplemented with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, and 100 μM isoGTP) and shaked at 200 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 1 h. Then, the recovery media was filled up with liquid growth media (2xYT media added with 50 mM K<sub>2</sub>HPO<sub>4</sub>, 0.5 mM IPTG, 100 μM isoC<sup>m</sup>TP, 100 μM isoGTP, 3 μg μL<sup>-1</sup> chloramphenicol, and 50 μg μL<sup>-1</sup> kanamycin for final concentrations) up to 1 mL and shaked at 600 rpm and 37 °C in a 12-well plate in the VWR – Incubation Microplate Shaker for 48 h. Plasmid isolations were performed for single 1 mL cultures. The high-copy plasmid pSB1K3 <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2201027">BBa_K2201027</a> was digested by the restriction enzymes <i>Pvu</i>I, <i>Nsi</i>I und <i>Bam</i>HI. The remaining low-copy plasmid pSB3C5 containing the UBP was then prepared for the Oxford Nanopore Sequencing.</p> |
| </div> | | </div> |
| | | |